Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 138 publications
Patient-derived organoid facilitating personalized medicine in non-small cell lung cancer: two case reports.
Journal: Frontiers in oncology
Published: July 28, 2025
Severe skin toxicity and early progression following neoadjuvant ensartinib and surgery in anaplastic lymphoma kinase-positive locally advanced lung cancer: a case report.
Journal: Frontiers in pharmacology
Published: July 25, 2025
Amylase-producing lung adenocarcinoma with an anaplastic lymphoma kinase fusion mutation: a case report.
Journal: Laboratory medicine
Published: June 25, 2025
Preclinical Prediction of Resistance Mutations and Proposal of Sequential Treatment Strategies for ALK-positive Lung Cancer Using Next-generation ALK Inhibitors.
Journal: Pharmaceutical research
Published: May 30, 2025
Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: April 23, 2025
Case Report: Treatment response of SQSTM1-ALK fusion lung adenocarcinoma to multiple ALK inhibitors.
Case Report: Treatment response of SQSTM1-ALK fusion lung adenocarcinoma to multiple ALK inhibitors.
Journal: Frontiers in pharmacology
Published: April 08, 2025
Properties of FDA-approved small molecule protein kinase inhibitors: A 2025 update.
Journal: Pharmacological research
Published: March 29, 2025
Organizing pneumonia in ALK+ non-small cell lung cancer treated with ceritinib: a case report.
Journal: Discover oncology
Published: March 10, 2025
Ensartinib in a primary pulmonary ALK-rearranged mesenchymal neoplasm harboring a novel HMBOX1::ALK fusion: a case report and literature review.
Journal: Frontiers in medicine
Published: February 28, 2025
Ensartinib (Ensacove) for non-small cell lung cancer.
Journal: The Medical letter on drugs and therapeutics
Published: February 13, 2025
Treatment of metastatic ALK-positive non-small cell lung cancer: indirect comparison of different ALK inhibitors using reconstructed patient data.
Journal: Frontiers in oncology
Published: January 25, 2025
A Recurrent Small Cell Lung Carcinoma Harboring an EML4-ALK Fusion Mutation with Sustained Response to Ensartinib: A Case Report.
Journal: Current oncology (Toronto, Ont.)
Published: January 05, 2025
Last Updated: 10/31/2025